Use of the quadrivalent (four-strain) human papillomavirus vaccine (4vHPV)—which was introduced in 2006—was associated with a 64% decrease in prevalence of the vaccine strains in girls and women 14 to 19 years old and a 34% drop in women 20 to 24 years old, according to a study yesterday in Pediatrics.
Provincial officials in China have reported two new cases of H7N9 avian flu, according to reports yesterday and today.
The first case is in Ningbo city in Zhejiang province in east central China, according to a China News story yesterday translated and posted by FluTrackers, an infectious disease news message board. The patient—whose age and sex were not specified—had contact with live poultry and is hospitalized.
The US Centers for Disease Control and Prevention (CDC) has replaced its longtime head of national lab regulation after a series of key lab safety breaches involving bioterror pathogens like Bacillus anthracis—which causes anthrax—and H5N1 avian flu viruses, USA Today reported yesterday.
Health plans in general are doing a poor job at raising human papillomavirus (HPV) vaccination levels in adolescent girls, according to researchers from the US Centers for Disease Control and Prevention (CDC) and their collaborators at Princeton University. The team published its findings in Morbidity and Mortality Weekly Report (MMWR).
Only about a third of US teen boys have received even one dose of human papillomavirus (HPV) vaccine, and only about one in seven has received the recommended three doses, with uptake a bit higher in some minority groups, according to a study from the Centers for Disease Control and Prevention (CDC) yesterday in Pediatrics.
Physicians' lukewarm communication and follow-through about human papillomavirus (HPV) vaccine may likely contributing to low vaccination levels, researchers reported today. A team from Harvard Medical School reported its findings in Cancer Epidemiology, Biomarkers, and Prevention.
Healthcare workers (HCWs) in Guinea last year had an incidence of Ebola virus disease 42 times higher than non-HCWs, and lab technicians, physicians, and men were especially hit hard, according to a report today in Morbidity and Mortality Weekly Report (MMWR).
A trial to see if a lower dose of one of the leading Ebola vaccine candidates can reduce reactions such as arthritis and skin rashes found that the effects persisted and that decreasing the dose had a negative impact on immune response. An international research team based in Switzerland published their findings on the lower VSV-EBOV dose yesterday in an early online edition of Lancet Infectious Diseases.
HPV vaccine uptake, though up slightly, was just 60% in girls and 42% in boys.
Two straight weeks of low influenza activity signal that the long 2014-15 flu season, marked by its heavy impact on seniors and poor vaccine performance, is drawing to an end, the Centers for Disease Control and Prevention (CDC) said in a short review of the season yesterday.